What species are susceptible to CWD infection?
The known natural hosts of CWD are elk (Cervus canadensis), mule deer (Odocoileus hemionus), white-tailed deer (O. virginianus), moose (Alces alces) [5] , and reindeer [4] . Red deer (C. elaphus) [3] and fallow deer (Dama dama) [3] are also susceptible to CWD via experimental transmission. Interspecies transmission of CWD to noncervid animals has not been observed under natural conditions. However, due to the shared habitats of free-ranging cervids with other wildlife or domestic species in CWD endemic areas, there is increasing concern over the susceptibility of certain species, especially livestock, to CWD. In cattle, only intracerebrally but not orally inoculated animals developed prion disease [3] . Prion transmission is most effective via the less physiological intracerebral route; thereby, CWD can be transmitted experimentally to goats, sheep, rodents, mink, ferrets, and squirrel monkeys.
From the human health perspective-Is CWD a matter of concern?
CWD is one of the most contagious prion diseases and the substantial presence in extraneural tissues; shedding of CWD prion infectivity in urine, feces, and saliva into the environment; and prion persistence for years are driving forces of CWD transmission [6] . Deer hunting and venison consumption are very common in North America. As the geographic distribution and case numbers of CWD are constantly growing [2] , exposure of humans to CWD prions becomes more likely. To date, bovine spongiform encephalopathy is the only example of interspecies transmission of prion disease to humans [7] . The potential zoonotic transmission of CWD is an alarming issue and still an open question [3, 8] .
Laboratory studies suggest that the risk of CWD transmission to humans is low. One group reported low conversion efficiency of human PrP C by CWD PrP Sc into the misfolded form using an in vitro amplification assay [9] . However, sole in vitro studies are not sufficient to assess the risk for humans exposed to CWD agents. Inoculation of "classical" CWD prions into transgenic mice overexpressing human PrP C did not result in disease [3] but it is not known whether humans resist infection with all natural CWD strains. Transmission experiments employing nonhuman primates as infection models are a matter of debate. Squirrel monkeys were susceptible to CWD infection [3] . Inoculation via different routes of CWD prions into macaques, which have a prion protein (PrP) sequence that differs more from human PrP than that of squirrel monkeys although macaques are genetically closer to humans [10] , is still a matter of debate [3] . We also can expect a long incubation period in nonhuman primates, as illustrated when sheep scrapie thought to be not zoonotic was transmitted to macaques [11] . With this in mind, studies in nonhuman primates are ongoing and it could take more than 10 years for the animals to develop disease. On the other hand, epidemiological studies did not show any correlation between CWD prion exposure and human prion disease, whether the cohort was large and population based [3] or small with case series [12] [13] [14] . During a routine surveillance over a period of 6 years (1993 to 1999) in Wyoming and Colorado, neither an overall increase in the incidence of Creutzfeldt-Jakob disease (CJD) [15] nor unusual prion disease subtypes or increased incidence in CJD patients who had regularly consumed venison [16, 17] was observed. These findings suggest a notable species barrier between cervids and humans; however, prion diseases are dynamic; interspecies passage of CWD can result in prion adaptation to new host species. Besides, the existence of more than one CWD strain [18] may contribute to higher heterogeneity in disease and transmission profiles [19] .
Can the species barrier for CWD to humans be crossed?
Although the evidence gathered so far is in favor of a low risk to transmit CWD to humans, results from in vitro studies indicated that the species barrier is not absolute.
We know now that the species barrier is not only regulated by the PrP primary structures of donor (PrP 
Can we stop CWD?
Even though management policies for captive animals through quarantine and depopulation of CWD-affected herds appear efficient, attempts to control CWD even in confined facilities failed because of persistence of infectivity in the environment. Managing CWD in free-ranging animals is an even bigger challenge. CWD will continue to expand in North America and other territories, exemplified by its unexpected emergence in Norway. The absence of an effective vaccine despite considerable efforts to develop this strategy makes complete eradication of CWD not realistic to date. Besides, long incubation periods, subtle early clinical signs, a resilient infectious agent in the environment, and incomplete understanding of transmission all constrain options for controlling CWD. Norwegian authorities decided to cull an entire herd of 2,500 reindeer and to prevent migration into this area where CWD was found as an attempt to stamp out the disease [21] . Less drastic but similar approaches were taken in North America with targeted culling of deer to reduce population densities and thereby minimize the risk of transmission. However, success was limited and, ultimately, environmental reservoirs of CWD prions may sustain disease incidence [3] .
Inherent difficulties in managing infected herds and premises underscore the need for aggressive surveillance to prevent introduction of infected carcasses to the human food chain.
Developing new noninvasive and preclinical diagnostic tools for live animals, e.g., by sampling their feces [22] , could help to delimit infected areas. Selecting resistant genotypes for breeding farmed cervids could reduce CWD as has been demonstrated for scrapie in sheep.
In summary, extensive research to learn more about CWD strain variability and transmission properties is necessary to predict the risk for humans. Effective vaccine strategies and decontamination of infected facilities and environmental reservoirs need to be developed to counteract the spread of CWD.
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